Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Stryker Corporation (SYK) Guidance & Earnings Results

On 2026-07-30 Stryker Corporation raised guidance: "Full-year 2026 organic net sales growth guidance narrowed to 8.3%-9.3%, adjusted EPS guidance to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SYKStryker CorporationFollow SYK — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
117.8B
P/E TTM
31.8
Dividend yield
1.1%
52-week
—
Next earnings
29 Oct, in 5 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
30 Jul 26RaisedFull-year 2026 organic net sales growth guidance narrowed to 8.3%-9.3%, adjusted EPS guidance to $14.95-$15.10 · full year
30 Apr 26ReaffirmedOrganic sales growth 8.0%-9.5%, adjusted EPS $14.90-$15.10 · full year
29 Jan 26RaisedFY2026 organic sales growth 8.0%-9.5% (vs FY2025 organic 10.3%); adjusted EPS $14.90-$15.10 (vs FY2025 $13.63, +9.4%-10.8%)
30 Oct 25RaisedOrganic sales growth guidance raised to 9.8-10.2%; adjusted EPS to $13.50-$13.60 · full year
31 Jul 25RaisedFY2025 organic net sales growth raised to 9.5%-10.0%; adjusted EPS raised to $13.40-$13.60; tariff impact ~$175M · full year

Stryker Corporation — questions

What guidance did Stryker Corporation give?
On 2026-07-30: "Full-year 2026 organic net sales growth guidance narrowed to 8.3%-9.3%, adjusted EPS guidance to $14.95-$15.10"
When does Stryker Corporation report earnings?
Stryker Corporation's next earnings report is expected on 2026-10-29.

Every figure on this page comes from Stryker Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.